1p/19q testing has no significance in the workup of glioblastomas

1p/19q testing has no significance in the workup of glioblastomas

ConclusionsThese data suggest that 1.) 1p/19q testing is not useful on gliomas that are histologically GBMs; 2.) codeletion testing should be reserved only for cases with compatible morphology; 3.) EGFR, 10q, and IDH1 testing can help act as safeguards against a falseā€positive 1p/19q result. (Source: Neuropathology and Applied Neurobiology)

MedWorm Sponsor Message: Have a look at The Cancer and Oncology Daily, the new cancer portal with all the latest cancer news and research powered by MedWorm, updated daily.

View Source